Physician

Alain Alvarez

According to 2025 Medicare claims, Alain Alvarez (NPI: 1841457496) practices rheumatology in the Naples-Marco Island, FL market, with the plurality of this provider's patient population coming from Collier, FL. This provider's primary affiliated billing organization is AMERICAN ARTHRITIS & RHEUMATOLOGY ASSOCIATES LLC (NPI: 1598205072; TIN: 831053374) and primary practice location at 34109-2765. Alvarez is affiliated with the Mosaic ACO (ACO ID: A5033), participating under the MSSP model.

Alvarez's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 645 traditional Medicare patients, billed 269,403 HCPCS/CPT codes, and received $2,408,652 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 2,445 prescription claims across 601 beneficiaries totaling $2,951,393 in drug costs, led by Humira(Cf) Pen (Adalimumab). 2020 DME data shows 12 claims. Open Payments data shows 191 records totaling $4,823. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $361,486 to $2,408,652. Similarly, Part D prescription costs have risen steadily, from $343,688 to $2,951,393. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	976	16,424	$361,486
2016	46	154	$7,456
2017	532	4,385	$141,558
2018	773	16,923	$299,952
2019	807	39,063	$756,029
2020	754	102,955	$1,570,181
2021	799	167,514	$1,863,601
2022	705	209,311	$2,018,059
2023	679	232,780	$2,001,658
2024	645	269,403	$2,408,652

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	331	1,091	$343,688
2016	351	1,611	$362,252
2017	453	2,321	$799,775
2018	540	2,491	$1,208,015
2019	561	2,891	$1,989,844
2020	583	3,085	$2,139,624
2021	604	2,602	$2,282,141
2022	727	2,696	$2,566,121
2023	733	2,918	$3,836,170
2024	601	2,445	$2,951,393

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	12	$1,582
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	103	497	$101
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	410	817	$101
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	95	113	$68
96401	Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle	135	1,003	$59
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	427	822	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	76	2,422	$667,728
Enbrel Sureclick	Etanercept	74	2,268	$611,541
Cosentyx Sensoready (2 Pens)	Secukinumab	19	1,098	$298,462
Rinvoq	Upadacitinib	29	1,470	$297,460
Taltz Autoinjector	Ixekizumab	12	504	$122,766

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	191	$4,823	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alain Alvarez?

Tedicare shows public-source Medicare data for Alain Alvarez (NPI 1841457496), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alain Alvarez have ACO affiliation data?

Alain Alvarez is shown with ACO affiliation data for Mosaic ACO (MSSP, ACO ID A5033).

What billing organization is linked to Alain Alvarez?

Alain Alvarez is linked to AMERICAN ARTHRITIS & RHEUMATOLOGY ASSOCIATES LLC (billing NPI 1598205072) in the available physician profile data.

Does Alain Alvarez have Open Payments data?

Alain Alvarez has 191 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.